Ginkgo Bioworks (DNA) Reports In-Line Q1 EPS, misses on revenue

Ginkgo Bioworks (NYSE: DNA) reported Q1 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $37.94 million versus the consensus estimate of $46.37 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus
• Sunstone Hotel Investors to sell Hyatt Regency San Francisco for $279M